Actualités

GE Vernova is quietly building embedded value with its long-term SMR investments.

SCHG, VUG, and QQQ each take a different structural approach to large-cap growth, and those differences compound into a significant performance gap over ten years. One fund has a defensible claim as the best vehicle for the AI era, but the case involves real tradeoffs most investors overlook.

Oklo's next-gen nuclear technology could deliver massive long-term returns, but investors should know a few things before diving into the stock.

Oklo had a disastrous market debut. Investors who held on to their shares, however, have had the last laugh.

Forecasts are rising for how much money Big Tech will throw at the AI data center build-out this year. But money may not get the job done if chips, skilled labor, and power bottlenecks stand in the way.

Oklo's Groves reactor milestone adds real-world nuclear operating experience, but larger Aurora projects still face regulatory and execution hurdles.

SpaceX is the largest space company, while Oklo is an early-stage energy company.

As AI fuels demand for power, these companies are well-positioned to meet the moment.

A nuclear energy company made a big breakthrough. Will it lead to bigger profits for these nuclear energy ETFs?

SMR's proposed TVA program could unlock licensing, engineering and equipment work tied to up to 6 GW of new nuclear capacity.

SMR's regulatory head start and $1.9B liquidity support commercialization, but its rich valuation raises the stakes for contract conversion.

OKLO's nuclear ambitions gained traction with first revenues and key project milestones, but rising costs and widening losses remain major hurdles.

Oklo Inc. has already achieved first criticality at its Groves low-power test reactor on private land in Texas and reported its first-ever quarterly sales of US$1.21 million, even as its quarterly net loss widened to US$48.54 million with a basic loss per share of US$0.28. This combination of technical progress and initial revenue, built on a greenfield site under the U.S. Department of Energy’s Reactor Pilot Program, is beginning to translate Oklo’s advanced reactor vision into real-world...

NuScale holds a regulatory edge no other SMR company can claim, yet its stock has shed nearly a third of its value in 2026 alone. Find out what specific catalysts would need to align before a return to $15 becomes a real conversation.

The company also revealed that its nuclear facility in Texas reached criticality.

Oklo just hit a nuclear milestone that took under a year to achieve, while AST SpaceMobile absorbed a nine-figure launch loss and kept building anyway. One bet runs on atoms, the other on orbits, and only one of them makes sense to own right now.

It's a bit of a speculative investment right now, but there are encouraging signs.

Oklo received a series of price target cuts from Wall Street analysts, even as retail sentiment on Stocktwits fell from ‘extremely bullish’ to ‘bullish’ over the past 24 hours.

Oklo just reported its first-ever quarterly revenue.

SMR's regulatory progress, supplier network and $1.9B liquidity support its outlook despite weak revenues and execution risks.

Oklo Inc. (NYSE:OKLO) just proved it can build a nuclear reactor as fast as it promised. On August 6, the company announced its Groves Isotope Test Reactor in Lockhart, Texas, achieved first criticality, a controlled, self-sustaining nuclear chain reaction, less than a year after groundbreaking. It’s the first project under the US Department of Energy’s […]

Oklo (NYSE:OKLO) announced a broad refresh of its executive leadership team, adding new heads across Product, Staff, Legal, Engineering, and Accounting. The company highlighted experience from organizations including the U.S. Nuclear Regulatory Commission, National Grid, and Joby Aviation among the new appointees. The reshaped leadership group is intended to support Oklo as it moves from pilot milestones toward commercial isotope production and closer regulatory engagement. For readers...

Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project

Centrus Energy (NYSE:LEU) reported second-quarter 2026 revenue growth and expanded its commercial backlog as the company advanced plans to build U.S. uranium-enrichment capacity for low-enriched uranium, or LEU, and high-assay low-enriched uranium, or HALEU. Revenue for the quarter ended June 30 ro

Groves facility reaches first criticality in under 11 months.

Moby summary of Oklo Inc.'s Q2 2026 earnings call

Oklo Inc (OKLO) reports a $81.6 million net loss but achieves first criticality at Groves facility and secures key DOE award, positioning for 2028 Aurora startup.

Oklo just posted its first real quarterly revenue and the stock surged, yet shares still sit 33% in the red for the year. A return to triple digits is mathematically possible, but it hinges on a very specific stack of catalysts falling into place.

Oklo achieved a crucial milestone.

Oklo posted revenue of $1.2 million in the second quarter, exceeding Street estimates of around $70,000, according to Fiscal.ai data